T. Rowe Price Associates’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-1,404,444
Closed -$33.8M 2604
2014
Q2
$33.8M Sell
1,404,444
-6,817,349
-83% -$164M 0.01% 980
2014
Q1
$49.6M Sell
8,221,793
-1,350,309
-14% -$8.14M 0.01% 866
2013
Q4
$57.2M Sell
9,572,102
-1,433,750
-13% -$8.57M 0.01% 789
2013
Q3
$57.3M Sell
11,005,852
-486,600
-4% -$2.54M 0.01% 768
2013
Q2
$41.5M Buy
+11,492,452
New +$41.5M 0.01% 844